Clinical Trial: Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An Efficacy and Safety Study of Intravenous Pantoprazole in the Prevention of Recurrent Peptic Ulcer Bleeding After Successful Hemostasis

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of intravenous pantoprazole in the prevention of rebleeding in patients with bleeding peptic ulcer disease after successful endoscopic hemostatic therapy.

Detailed Summary:
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Wyeth is now a wholly owned subsidiary of Pfizer

Dates:
Date Received: June 26, 2002
Date Started: April 2001
Date Completion:
Last Updated: February 7, 2013
Last Verified: February 2013